ObsEva (NASDAQ:OBSV) Now Covered by StockNews.com

Analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Sunday. The brokerage set a “hold” rating on the stock.

ObsEva Price Performance

ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14. The company has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.